Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.

Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73.

Recent gene expression profiling studies have identified five breast cancer subtypes, of which the basal-like subtype is the most aggressive. Basal-like breast cancer poses serious clinical challenges as there are currently no targeted therapies available to treat it. Although there is increasing ev...

Full description

Bibliographic Details
Main Authors: Wong, Su Wei, Tiong, Kai Hung, Kong, Kong, Yue, Yuen Chee, Chua, Choon Hooi, Lim, Jae Ying, Lee, Chai Yuin, Quah, Sean I., Fow, Cindy, Chung, Cyril, So, Irene, Tan, Boon Shing, Choo, Heng Lungh, Rosli, Rozita, Cheong, Soon Keng, Leong, Chee Onn
Format: Article
Language:English
English
Published: Springer Verlag 2011
Online Access:http://psasir.upm.edu.my/id/eprint/24421/
http://psasir.upm.edu.my/id/eprint/24421/1/Rapamycin%20synergizes%20cisplatin%20sensitivity%20in%20basal.pdf

Internet

http://psasir.upm.edu.my/id/eprint/24421/
http://psasir.upm.edu.my/id/eprint/24421/1/Rapamycin%20synergizes%20cisplatin%20sensitivity%20in%20basal.pdf

Similar Items